Australia markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
29.78-0.72 (-2.36%)
At close: 04:00PM EDT
30.00 +0.22 (+0.74%)
After hours: 05:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 821.42M
Enterprise value 564.95M
Trailing P/E N/A
Forward P/E 2.48
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.36
Price/book (mrq)3.11
Enterprise value/revenue 5.11
Enterprise value/EBITDA -2.04

Trading information

Stock price history

Beta (5Y monthly) 2.65
52-week change 314.10%
S&P500 52-week change 326.36%
52-week high 343.81
52-week low 317.52
50-day moving average 330.84
200-day moving average 329.42

Share statistics

Avg vol (3-month) 3511.46k
Avg vol (10-day) 3457.26k
Shares outstanding 526.93M
Implied shares outstanding 626.93M
Float 824.58M
% held by insiders 18.74%
% held by institutions 198.75%
Shares short (30 Apr 2024) 44.92M
Short ratio (30 Apr 2024) 410.32
Short % of float (30 Apr 2024) 428.72%
Short % of shares outstanding (30 Apr 2024) 418.26%
Shares short (prior month 28 Mar 2024) 44.81M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Nov 2017
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 316 Nov 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -86.16%
Operating margin (ttm)-77.90%

Management effectiveness

Return on assets (ttm)-17.22%
Return on equity (ttm)-36.17%

Income statement

Revenue (ttm)124.53M
Revenue per share (ttm)4.66
Quarterly revenue growth (yoy)-52.70%
Gross profit (ttm)N/A
EBITDA -119.29M
Net income avi to common (ttm)-107.3M
Diluted EPS (ttm)-4.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)288.4M
Total cash per share (mrq)10.71
Total debt (mrq)31.92M
Total debt/equity (mrq)12.09%
Current ratio (mrq)3.26
Book value per share (mrq)9.81

Cash flow statement

Operating cash flow (ttm)12.21M
Levered free cash flow (ttm)-4.99M